About AGTC Funds:
Applied Genomic Technology Capital Funds
is a specialty venture capital group focused on investment
opportunities enabled by the genomic revolution. AGTC
Funds invests in private companies that apply genomic
information and technologies to develop products or
services that create significant shareholder value.
Formed by NewcoGen Group, in partnership with OneLiberty
Ventures, AGTC Funds' limited partners include both
institutional investors and corporations with a strategic
interest in genomics, including Affymetrix, Antigenics,
Compaq Computer Corporation and Millennium Pharmaceuticals,
Inc. As the first specialty fund focused on this sector,
AGTC expects to play a leadership role in selecting,
funding and developing new genomics application companies.
To learn more about AGTC funds,
visit their web site at http://www.agtcfunds.com.
About Mason Wells:
Mason Wells began in 1982 as the merchant
banking arm of the Marshall & Ilsley Corporation,
the oldest existing bank operating in the Great Lakes
Region with its origin dating to 1847. In 1998 Mason
Wells was created as an independent management company
to raise its first independent fund with capital provided
by over twenty Midwest institutional investors and
business partners. Mason Wells is currently managing
over $350 million of investments in a wide range of
companies in the biomedical and information technology
fields.
To learn more about Mason Wells,
visit their web site at http://www.masonwells.com.
About Seaflower Ventures:
Seaflower Ventures invests in promising,
early-stage biomedical firms and considers seed and
first-round investments in companies in most segments
of the biomedical industry, including biotechnology,
medical devices, healthcare information technology,
and healthcare services. Seaflower currently manages
three funds: The Seaflower Health & Technology
Fund, L.L.C., a $5 million seed venture capital fund;
the Seaflower BioVenture Fund II, L.L.C., a $10 million
venture fund; and the J&L Sherblom Fund, L.L.C.,
a focused equity fund. Typical investments range from
$250,000 to $1,250,000 for promising opportunities.
To learn more about Seaflower
Ventures, and review its portfolio of companies, visit
their web site at http://www.seaflower.com.
|
